Results 221 to 230 of about 159,964 (350)

Aquaporin‐1 differentiates intrahepatic cholangiocarcinoma from liver metastases of pancreatic ductal adenocarcinoma

Histopathology, EarlyView.
Differentiating intrahepatic CCA from PDAC metastatic to the liver is critical for the clinical management of patients with pancreatobiliary cancers. AQP1 has demonstrated an excellent discriminatory performance in this clinical scenario. Aims Differentiating intrahepatic cholangiocarcinoma (iCCA) from metastatic ductal adenocarcinoma of the pancreas ...
Leoncini Giuseppe, Barella Marco, Droz Dit Busset Michele, Gentili Marco, Bodini Beatrice, Ronchetti Simona, Cari Luigi, Mazzaferro Vincenzo   +7 more
wiley   +1 more source

Table 1_Identifying novel biomarkers for biliary tract cancer based on volatile organic compounds analysis and machine learning.docx

Jingrong Qian (18618229), Qi Liu (33068), Jue Wang (58890), Xuewei Zhuang (332086), Jun Fang (44152)   +4 more
openalex   +1 more source

The increasing burden of early-onset pancreatic and biliary tract cancers: a review of risk factors [PDF]

Alice Boilève, Mathias Brügel, Maxime Rémond, Marine Valéry, Michel Ducreux, Anthony Turpin, Cristina Smolenschi   +6 more
openalex   +1 more source

GLIM Criteria as Prognostic Factor in Patients Undergoing Adjuvant S-1 Chemotherapy for Biliary Tract Cancer. [PDF]

Cancer Diagn Progn
Konaka R, Yanagimoto H, Tsugawa D, Akita M, Mizumoto T, Yoshida T, Sou S, Ishida J, Nanno Y, Urade T, Fukushima K, Gon H, Komatsu S, Asari S, Kido M, Toyama H, Fukumoto T.   +16 more
europepmc   +1 more source

Innate Immune Activation Is a Strong Suppressor of CCL22 and Impedes Regulatory T Cell–Dendritic Cell Interaction

Immunology, EarlyView.
During homeostasis, CCL22 is secreted by dendritic cells (DC), which mediate contacts between regulatory T cells (Treg) and DC to maintain immune balance. Activation of innate immunity via microbes or pattern recognition receptor (PRR) agonists induces the secretion of several soluble factors (e.g., type I and II interferons, IL‐10), which mediate ...
Ignazio Piseddu, Jan Gärtig, Stephan Eiber, Stefan Moder, Raffael Thaler, Matthias Thaler, Juliane Gruen, Marlies Vornhülz, Kevin Bahner, Luana Messa, Benjamin Kühnemuth, Jennifer Müller, Konstantin Schnell, Antonia Beimert, Carolin Perleberg, Natascha Röhrle, Maximilian Martin Ludwig Knott, Linda Hammann, Vanessa Wittmann, Patrick Layritz, Moritz Rapp, Carole Bourquin, Julia Mayerle, Stefan Endres, David Anz   +24 more
wiley   +1 more source

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of sacituzumab govitecan for breast cancer, fruquintinib for colorectal cancer, amivantamab for lung cancer, repotrectinib for lung cancer, tasurgratinib for biliary tract cancer, enfortumab vedotin plus pembrolizumab for urothelial cancer, and dabrafenib plus trametinib for glioma in Japan [PDF]

Noriomi Matsumura, Masaki Mandai
openalex   +1 more source

Chemotherapy tolerance and continuity are prognostic for overall survival in patients with localized and advanced biliary tract cancer. [PDF]

Turk J Med Sci
Akkuş E, Kubilay Tolunay P, Köksoy EB, Yaşar HA.   +3 more
europepmc   +1 more source

Surgeon Regret and Shared Decision‐Making for Hepatopancreatobiliary Cancer: A Survey of Australia and New Zealand

ANZ Journal of Surgery, EarlyView.
Joshua G. Kovoor, John M. Kefalianos, Harleen K. Aulakh, Angad Singh, Vincent Lam, Vijayaragavan Muralidharan, Saxon Connor, Thomas J. Hugh   +7 more
wiley   +1 more source

Vaginal Microbiota and Ovarian Cancer: A New Frontier in Immunomodulation and Diagnosis

Immunology, EarlyView.
Microbial imbalance, dysbiosis, plays a role in ovarian carcinogenesis by interacting with the immune system and altering inflammatory pathways, notably Th17 pathways. In contrast, eubiosis, characterised by Lactobacillus dominance, protects against infections and maintains hormone metabolism.
Wafa Babay, Mariem Garci, Ahmed Baligh Laaribi, Nabil Mathlouthi, Imene Ouzari   +4 more
wiley   +1 more source

Therapeutic T cells with 3-in-1 strategy for the treatment of biliary tract cancer. [PDF]

Cell Rep Med
Wan X, Zhao J, Yang X, Mou X, Liu B, Gao B, Gu W, Zhao H.   +7 more
europepmc   +1 more source